Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients

Clinical trial NCT04473703 · UNKNOWN

Trial details

NCT number: NCT04473703
Sponsor: Shanghai Chest Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Adverse Reactions Immune Checkpoint Inhibitor Non-Small Cell Lung Cancer Patients Cardiac Event

Start date: 2020-08-01
Primary completion: 2022-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.